Skip to content
2000
Volume 20, Issue 8
  • ISSN: 1570-193X
  • E-ISSN: 1875-6298

Abstract

Malaria is a parasitic infection caused by Plasmodium parasites that are transmitted to humans through the bite of infected Anopheles mosquitoes. Malaria continues to contribute unacceptably high rates of sickness and death. Natural product compounds have long been recognized as one of valuable natural remedy resources with promising structural motif pools for the development of first-line drugs. Resistance to conventional treatments such as chloroquine, mefloquine, and artemisinin- based combination therapy (ACT) by the causal agent, the Plasmodium parasite, is a major concern in malaria treatment and prevention globally. Given the parasites' resistance to several current treatment regimens, innovative antimalarial chemotherapeutic medicines derived from tetramic acid alkaloids are desperately needed. In this review, new and old antimalarial alkaloids identified and reported recently from 2017 to 2021 are presented. Several compounds with promising antimalarial activity are identified from several subclasses of alkaloids. It is hoped that this review report will inspire future research into the compounds' toxicity and in vivo efficacy, to exploit this intriguing compound as antimalarial drugs.

Loading

Article metrics loading...

/content/journals/mroc/10.2174/1570193X20666221018090845
2023-12-01
2025-07-09
Loading full text...

Full text loading...

/content/journals/mroc/10.2174/1570193X20666221018090845
Loading

  • Article Type:
    Review Article
Keyword(s): Alkaloids; antimalarial; antiplasmodial activity; malaria; plant; Plasmodium falciparum
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test